Screening of Living Kidney Donors for Genetic Diseases: PRO
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Screening of Living Kidney Donors for Genetic Diseases: Commentary.
Steiner R Kidney360. 2024; 5(10):1419-1421.
PMID: 38748489 PMC: 11556911. DOI: 10.34067/KID.0000000000000470.
References
1.
Groopman E, Marasa M, Cameron-Christie S, Petrovski S, Aggarwal V, Milo-Rasouly H
. Diagnostic Utility of Exome Sequencing for Kidney Disease. N Engl J Med. 2018; 380(2):142-151.
PMC: 6510541.
DOI: 10.1056/NEJMoa1806891.
View
2.
Caliskan Y, Safak S, Oto O, Velioglu A, Yelken B, Mirioglu S
. Propensity score-matched analysis of long-term outcomes for living kidney donation in alternative complement pathway diseases: a pilot study. J Nephrol. 2023; 36(4):979-986.
DOI: 10.1007/s40620-023-01588-x.
View
3.
Caliskan Y, Lee B, Whelan A, Abualrub F, Lentine K, Jittirat A
. Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment. Curr Transplant Rep. 2022; 9(2):127-142.
PMC: 9236183.
DOI: 10.1007/s40472-021-00340-3.
View
4.
Thomas C, Daloul R, Lentine K, Gohh R, Anand P, Rasouly H
. Genetic evaluation of living kidney donor candidates: A review and recommendations for best practices. Am J Transplant. 2023; 23(5):597-607.
DOI: 10.1016/j.ajt.2023.02.020.
View
5.
Oto O, Safak S, Mirioglu S, Yelken B, Velioglu A, Dirim A
. Long-Term Outcomes of Living-Related Kidney Donation for Alport Syndrome Spectrum: A Propensity Score-Matched Analysis. Am J Nephrol. 2022; 53(8-9):628-635.
DOI: 10.1159/000527180.
View